Hospital doctor, with interests in liver medicine, transplantation and inflammatory bowel disease. Combat sports’ enthusiast, and occasional stand up comic.https://bsky.app/profile/cholestasisdoc.bsky.socialhttps://bsky.app/profile/cholestasisdoc.bsky.social/post/3lf5gs57jgs2mNew from us: our trial protocol for faecal microbiota transplantation to treat people living with PSC and IBD. Actively recruiting! @bhmullish.bsky.social @nabilquraishi.bsky.social @alanmcn1.bsky.social @pscsupport.bsky.social https://bmjopen.bmj.com/content/bmjopen/15/1/e095392.full.pdf07 Jan 2025 10:27 +0000at://did:plc:y2bycz6agtfyu5lu2o7uv77p/app.bsky.feed.post/3lf5gs57jgs2mhttps://bsky.app/profile/cholestasisdoc.bsky.social/post/3le7nviyeyc2pAgree that mRNA vaccine technology needs deeper evaluation. @fda.gov should provide further details in due course. https://www.bmj.com/content/387/bmj.q2852.full26 Dec 2024 14:14 +0000at://did:plc:y2bycz6agtfyu5lu2o7uv77p/app.bsky.feed.post/3le7nviyeyc2phttps://bsky.app/profile/cholestasisdoc.bsky.social/post/3ldbf6cdovk2yNew work from us: Oral vancomycin is associated with attenuation in IBD activity in people with PSC. We also studied changes in gut microbiome profile, and key transcriptomic and metabolomic features. https://academic.oup.com/ecco-jcc/advance-article/doi/10.1093/ecco-jcc/jjae189/792393014 Dec 2024 13:18 +0000at://did:plc:y2bycz6agtfyu5lu2o7uv77p/app.bsky.feed.post/3ldbf6cdovk2y